Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 38.00% is 24% above its 5-year average of 30.59%, around the middle of its 5-year range (16.69%–48.03%).
As of the fiscal period ended Sunday, June 28, 2026. 4.81% below its 12-month average of 39.92%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-28): 38.00%.
DEBT TO ASSETS RATIO
38.00%
DEBT TO ASSETS RATIO AVG TTM
39.92%
DEBT TO ASSETS RATIO AVG 3Y
36.10%
DEBT TO ASSETS RATIO AVG 5Y
30.59%
DEBT TO ASSETS RATIO AVG 10Y
27.91%
DEBT TO ASSETS RATIO AVG 15Y
30.13%
DEBT TO ASSETS RATIO AVG 20Y
30.29%
CURRENT VS TTM AVG
-4.81%
CURRENT VS 3Y AVG
+5.28%
CURRENT VS 5Y AVG
+24.21%
CURRENT VS 10Y AVG
+36.17%
CURRENT VS 15Y AVG
+26.11%
CURRENT VS 20Y AVG
+25.44%
SECTOR MEDIAN · HEALTHCARE
0.29%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
+13233.33%
vs the sector median at left
Illumina, Inc.
Market Cap
$41.31B
Debt to Assets Ratio
38.00%
TTM Avg
39.92%
3Y Avg
36.10%
5Y Avg
30.59%
Market Cap
$40.89B
Debt to Assets Ratio
0.32%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$46.04B
Debt to Assets Ratio
0.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$47.38B
Debt to Assets Ratio
0.28%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$48.72B
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$49.03B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Illumina, Inc. (ILMN) | $41.31B | 38.00% | 39.92% | 36.10% | 30.59% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $40.89B | 0.32% | N/A | N/A | N/A |
| Waters Corporation (WAT)vs › | $41.75B | 0.21% | N/A | N/A | N/A |
| IQVIA Holdings Inc. (IQV)vs › | $42.50B | 0.54% | N/A | N/A | N/A |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $46.04B | 0.42% | N/A | N/A | N/A |
| Humana Inc. (HUM)vs › | $46.63B | 0.25% | N/A | N/A | N/A |
| Agilent Technologies, Inc. (A)vs › | $47.38B | 0.28% | N/A | N/A | N/A |
| Becton, Dickinson and Company (BDX)vs › | $48.72B | 0.33% | N/A | N/A | N/A |
| Edwards Lifesciences Corporation (EW)vs › | $49.03B | 0.05% | N/A | N/A | N/A |
| Biogen Inc. (BIIB)vs › | $32.49B | 0.26% | N/A | N/A | N/A |
Debt/Assets
38.0%
Debt/Equity
0.89
Current Ratio
1.80
Interest Coverage
8.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-28 | 38.00% |
| 2026-03-29 | 38.79% |
| 2025-12-28 | 38.43% |
| 2025-09-28 | 41.70% |
| 2025-06-29 | 42.68% |
| 2025-03-30 | 42.17% |
| 2024-12-29 | 41.60% |
| 2024-09-29 | 44.46% |
| 2024-06-30 | 48.03% |
| 2024-03-31 | 22.67% |
| 2023-12-31 | 22.37% |
| 2023-10-01 | 22.45% |
| 2023-07-02 | 25.89% |
| 2023-04-02 | 25.92% |
| 2022-12-31 | 29.02% |
| 2022-10-02 | 22.80% |
| 2022-07-03 | 16.77% |
| 2022-04-03 | 17.12% |
| 2021-12-31 | 16.69% |
| 2021-10-03 | 16.84% |
| 2021-07-04 | 28.08% |
| 2021-04-04 | 32.86% |
| 2020-12-31 | 25.13% |
| 2020-09-27 | 25.73% |
| 2020-06-28 | 26.09% |
| 2020-03-29 | 26.07% |
| 2019-12-31 | 25.71% |
| 2019-09-29 | 26.39% |
| 2019-06-30 | 26.70% |
| 2019-03-31 | 34.01% |
| 2018-12-31 | 28.70% |
| 2018-09-30 | 29.10% |
| 2018-07-01 | 23.04% |
| 2018-04-01 | 24.00% |
| 2017-12-31 | 22.67% |
| 2017-10-01 | 23.42% |
| 2017-07-02 | 24.17% |
| 2017-04-02 | 22.97% |
| 2016-12-31 | 24.51% |
| 2016-10-02 | 24.65% |
| 2016-07-03 | 25.89% |
| 2016-04-03 | 26.96% |
| 2015-12-31 | 29.57% |
| 2015-09-27 | 29.73% |
| 2015-06-28 | 35.19% |
| 2015-03-29 | 37.19% |
| 2014-12-31 | 38.68% |
| 2014-09-28 | 39.07% |
| 2014-06-29 | 41.88% |
| 2014-03-30 | 27.77% |
| 2013-12-31 | 28.77% |
| 2013-09-29 | 30.50% |
| 2013-06-30 | 30.17% |
| 2013-03-31 | 31.37% |
| 2012-12-31 | 32.83% |
| 2012-09-30 | 34.19% |
| 2012-07-01 | 35.11% |
| 2012-04-01 | 35.45% |
| 2011-12-31 | 36.77% |
| 2011-10-02 | 37.21% |
| 2011-07-03 | 35.35% |
| 2011-04-03 | 35.96% |
| 2010-12-31 | 16.94% |
| 2010-10-03 | 17.74% |
| 2010-07-04 | 18.31% |
| 2010-04-04 | 19.63% |
| 2009-12-31 | 20.29% |
| 2009-09-27 | 18.47% |
| 2009-06-28 | 18.94% |
| 2009-03-29 | 20.02% |
| 2008-12-31 | 29.05% |
| 2008-09-28 | 29.43% |
| 2008-06-29 | 41.79% |
| 2008-03-30 | 42.75% |
| 2007-12-31 | 40.50% |
| 2007-09-30 | 49.37% |
| 2007-07-01 | 51.71% |
| 2007-04-01 | 53.86% |
| 2006-12-31 | 0.02% |
| 2006-10-01 | 0.04% |
| 2006-07-02 | 0.05% |
| 2006-04-02 | 0.13% |
| 2005-12-31 | 0.17% |
| 2005-10-02 | 0.00% |
| 2005-07-03 | 0.00% |
| 2005-04-03 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-10-03 | 0.00% |
| 2004-06-27 | 20.10% |
| 2004-03-28 | 25.90% |
| 2003-12-31 | 25.82% |
| 2003-09-28 | 24.27% |
| 2003-06-29 | 24.37% |
| 2003-03-30 | 22.54% |
| 2002-12-31 | 21.57% |
| 2002-09-29 | 20.33% |
